FYERS
Fredun Pharmaceuticals1473.55
+18.65 (+1.28%)

Fredun Pharmaceuticals Share Price

1473.55+18.65 (+1.28%)
+184.48% past 1 Year

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---40%
---65%
-54%74%181%
15%15%15%16%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
FREDUN-B
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,785₹425150 Cr38.778.2958.23₹11479 Cr
9,975₹266265 Cr91.0334.04128.41₹2568 Cr
4,646.55₹176301 Cr8314.04106.21₹2163 Cr
2,310.25₹125352 Cr93.568.1733.94₹889 Cr
1,260.2₹123591 Cr27.399.4262.53₹5040 Cr
1,371.5₹114351 Cr40.8411.0859.2₹4196 Cr
1,391₹112474 Cr38.8210.8652.6₹3879 Cr
2,493.15₹102315 Cr45.6217.2376.26₹1913 Cr
1,697.2₹97757 Cr26.3317.9596.84₹3505 Cr
2,025₹92007 Cr16.6430.95154.35₹5333 Cr
1,473.55₹2492 Cr56.867.9431.66₹33 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
₹228 Cr₹213 Cr₹161 Cr₹145 Cr₹120 Cr₹167 Cr
₹228 Cr₹213 Cr₹161 Cr₹145 Cr₹120 Cr₹167 Cr
₹199 Cr₹187 Cr₹136 Cr₹125 Cr₹104 Cr₹152 Cr
₹33 Cr₹29 Cr₹26 Cr₹22 Cr₹17 Cr₹17 Cr
₹9 Cr₹14 Cr₹11 Cr₹8 Cr₹7 Cr₹8 Cr
₹21 Cr₹11 Cr₹14 Cr₹13 Cr₹9 Cr₹7 Cr
₹13 Cr₹11 Cr₹10 Cr₹9 Cr₹7 Cr₹6 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025
——
₹5 Cr₹5 Cr
₹14 Cr₹0
₹259 Cr₹137 Cr
₹259 Cr₹137 Cr
₹278 Cr₹141 Cr
-₹1,000₹0
₹56 Cr₹10 Cr
₹7 Cr₹4 Cr
₹0₹2,000
₹4 Cr₹4 Cr
₹67 Cr₹18 Cr
——
₹88 Cr₹145 Cr
₹53 Cr₹26 Cr
₹146 Cr₹151 Cr
₹10 Cr₹7 Cr
₹297 Cr₹328 Cr
₹642 Cr₹487 Cr
₹222 Cr₹167 Cr
——
₹148 Cr₹75 Cr
₹30 Cr₹22 Cr
₹118 Cr₹53 Cr
₹2 Cr₹2 Cr
₹2 Cr₹2 Cr
₹12 Cr₹5 Cr
₹11 Cr₹76 L
₹144 Cr₹60 Cr
——
₹270 Cr₹240 Cr
₹93 Cr₹177 Cr
₹65 Cr₹5 Cr
₹7 Cr₹3 Cr
₹64 Cr₹2 Cr
₹498 Cr₹427 Cr
₹201 Cr₹99 Cr
₹642 Cr₹487 Cr
₹483₹299
₹483₹299

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025
₹35 Cr₹27 Cr
₹46 Cr₹28 Cr
-₹69 Cr-₹72 Cr
₹12 Cr-₹17 Cr
₹12 Cr-₹17 Cr
-₹74 Cr-₹6 Cr
₹121 Cr₹27 Cr
₹60 Cr₹4 Cr
₹5 Cr₹2 Cr
₹65 Cr₹5 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Fredun Pharmaceuticals Ltd Share Price Today

The Fredun Pharmaceuticals Ltd share price today is ₹1357.5. During the trading session, the Fredun Pharmaceuticals Ltd share price opened at ₹1404.5 and recorded an intraday high of ₹1407.3 and a low of ₹1334.1. Last closing price was ₹1404.5. Over the past 52 weeks, the Fredun Pharmaceuticals Ltd share price has ranged between ₹1195.2 and ₹1590. The current Fredun Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.